The Microcap Kitchen: Stocks 5¢ to $5 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: ksuave	12/7/2006 8:32:45 PM
	Read Replies (2) of 120409

RPBIF -- Very nice pr. Response Biomedical Announces Strategic Alliance with 3M To Commercialize Rapid Infectious Disease Tests Thursday December 7, 7:26 pm ET Initial Product Launch Expected in 2007 3M Makes Equity Investment in Response Biomedical VANCOUVER, BC, and ST. PAUL, MN, Dec. 7 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX-V: RBM, OTCBB: RPBIF) announced today that it has entered into a worldwide, exclusive agreement with 3M Company (NYSE: MMM - News) through its medical division to pursue the development and commercialization of diagnostic products targeting hospital and community acquired infectious diseases using Response Biomedical's RAMP® testing platform. As part of this collaboration, 3M is making a US $8 million equity investment in Response Biomedical, representing approximately a 13 percent ownership position. Whole release: biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next